Programmable starving-photodynamic synergistic cancer therapy

  • Leli Zeng (曾乐立)
  • Kai Huang (黄凯)
  • Yilin Wan (万艺林)
  • Jing Zhang (张景)
  • Xikuang Yao (姚锡矿)
  • Chao Jiang (蒋超)
  • Jing Lin (林静)
  • Peng Huang (黄鹏)Email author


Synergistic therapy combines multiple therapeutic approaches in one shot, thus could significantly amplify the therapeutic effects. However, how to design the desirable combination to maximize the synergistic effect is still a big challenge in cancer management. Herein, a nano-agent composed of glucose oxidase (GOx) and upconversion nanoparticles (UCNPs) were constructed for programmable starving-photodynamic synergistic cancer therapy through cascade glucose oxidation and hydrogen peroxide photolysis. In this nanoagent, GOx modulated the tumor glucose metabolism and consumed the β-D-glucose to produce H2O2. The glucose depletion induced “starvation” in cancer cells and caused cell death. Afterwards, the generated H2O2 was photolyzed by the invisible ultraviolet emission of UCNPs under near-infrared light excitation at 980 nm. The toxic hydroxyl radicals produced by photolysis further induced cancer cell death. Both in vitro and in vivo experiments confirmed that this starving-photodynamic synergistic therapy significantly outran any single therapy. This study paves an avenue to design programmable starving-photodynamic synergistic therapy for cancer management.


upconversion nanoparticles starvation therapy photodynamic therapy synergistic cancer therapy 



协同治疗是指将多种治疗方法联合在一起使用, 从而显著增强治疗效果. 然而, 如何设计出理想的组合以最大限度地发挥协同效应仍是肿瘤治疗的一大挑战. 在此, 我们构建了一种由葡萄糖氧化酶修饰的上转换纳米制剂, 用于程序化的肿瘤饥饿-光动力协同治疗研究. 葡萄糖氧化酶催化氧化肿瘤内的葡萄糖并产生过氧化氢, 该过程消耗葡萄糖和氧气, 使得肿瘤细胞缺乏营养物质处于“饥饿”状态, 导致细胞死亡. 并且在980 nm的近红外光激发下, 上转换纳米颗粒激发产生紫外可见光, 将双氧水裂解成毒性更强的羟基自由基, 进一步杀死肿瘤细胞. 体外和体内实验均证实这种饥饿-光动力协同治疗明显优于任何单一治疗. 本研究为设计程序可控的饥饿-光动力协同治疗提供了理论支撑.



This work was financially supported by the National Natural Science Foundation of China (21807073, 31771036 and 51703132), the Basic Research Program of Shenzhen (JCYJ20170818144745087, JCYJ20180507182413022 and JCYJ20170412111100742), Guangdong Province Natural Science Foundation of Major Basic Research and Cultivation Project (2018B030308003), Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China (161032), and China Postdoctoral Science Foundation (2018M630987 and 2019T120752). We thank Instrumental Analysis Center of Shenzhen University (Lihu Campus).

Author contributions

Zeng L, Huang K and Huang P conceived the idea, proposed the strategy, performed the experiments and wrote the manuscript. Wan Y, Zhang J, and Jiang C performed the cell and animal experiments. Yao X and Lin J helped writing and modifying the manuscript. Huang P supervised the study, designed the project, evaluated the data and wrote the manuscript.

Supplementary material

40843_2019_1226_MOESM1_ESM.pdf (2.3 mb)
Programmable starving-photodynamic synergistic cancer therapy


  1. 1.
    Song X, Xu J, Liang C, et al. Self-supplied tumor oxygenation through separated liposomal delivery of H2O2 and catalase for enhanced radio-immunotherapy of cancer. Nano Lett, 2018, 18: 6360–6368CrossRefGoogle Scholar
  2. 2.
    Zhang MK, Li CX, Wang SB, et al. Tumor starvation induced spatiotemporal control over chemotherapy for synergistic therapy. Small, 2018, 14: 1803602CrossRefGoogle Scholar
  3. 3.
    Feng W, Han X, Wang R, et al. Nanocatalysts-augmented and photothermal-enhanced tumor-specific sequential nanocatalytic therapy in both NIR-I and NIR-II biowindows. Adv Mater, 2018, 55: 1805919CrossRefGoogle Scholar
  4. 4.
    Song R, Zhang M, Liu Y, et al. A multifunctional nanotheranostic for the intelligent MRI diagnosis and synergistic treatment of hypoxic tumor. Biomaterials, 2018, 175: 123–133CrossRefGoogle Scholar
  5. 5.
    Chen W, Liu J, Wang Y, et al. A C5N2 nanoparticle based direct nucleus delivery platform for synergistic cancer therapy. Angew Chem Int Ed, 2019, 58: 6290–6294CrossRefGoogle Scholar
  6. 6.
    Fan W, Yung B, Huang P, et al. Nanotechnology for multimodal synergistic cancer therapy. Chem Rev, 2017, 117: 13566–13638CrossRefGoogle Scholar
  7. 7.
    Yang B, Chen Y, Shi J. Reactive oxygen species (ROS)-based nanomedicine. Chem Rev, 2019, 119: 4881–4985CrossRefGoogle Scholar
  8. 8.
    Jiang Y, Li J, Zeng Z, et al. Organic photodynamic nanoinhibitor for synergistic cancer therapy. Angew Chem, 2019, 131: 8245–8249CrossRefGoogle Scholar
  9. 9.
    Zhang X, Du J, Guo Z, et al. Efficient near infrared light triggered nitric oxide release nanocomposites for sensitizing mild photothermal therapy. Adv Sci, 2019, 6: 1801122CrossRefGoogle Scholar
  10. 10.
    Zeng L, Gupta P, Chen Y, et al. The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials. Chem Soc Rev, 2017, 46: 5771–5804CrossRefGoogle Scholar
  11. 11.
    Hao H, Sun M, Li P, et al. In situ growth of a cationic polymer from the N-terminus of glucose oxidase to regulate H2O2 generation for cancer starvation and H2O2 therapy. ACS Appl Mater Interfaces, 2019, 11: 9756–9762CrossRefGoogle Scholar
  12. 12.
    Zhang L, Wang Z, Zhang Y, et al. Erythrocyte membrane cloaked metal-organic framework nanoparticle as biomimetic nanoreactor for starvation-activated colon cancer therapy. ACS Nano, 2018, 12: 10201–10211CrossRefGoogle Scholar
  13. 13.
    He T, Xu H, Zhang Y, et al. Glucose oxidase-instructed traceable self-oxygenation/hyperthermia dually enhanced cancer starvation therapy. Theranostics, 2019, doi: CrossRefGoogle Scholar
  14. 14.
    Fu LH, Qi C, Hu YR, et al. Glucose oxidase-instructed multimodal synergistic cancer therapy. Adv Mater, 2019, 31: 1808325CrossRefGoogle Scholar
  15. 15.
    Huo M, Wang L, Chen Y, et al. Tumor-selective catalytic nano-medicine by nanocatalyst delivery. Nat Commun, 2017, 8: 357CrossRefGoogle Scholar
  16. 16.
    Zhang R, Feng L, Dong Z, et al. Glucose & oxygen exhausting liposomes for combined cancer starvation and hypoxia-activated therapy. Biomaterials, 2018, 162: 123–131CrossRefGoogle Scholar
  17. 17.
    Fu LH, Qi C, Lin J, et al. Catalytic chemistry of glucose oxidase in cancer diagnosis and treatment. Chem Soc Rev, 2018, 47: 6454–6472CrossRefGoogle Scholar
  18. 18.
    Fan W, Lu N, Huang P, et al. Glucose-responsive sequential generation of hydrogen peroxide and nitric oxide for synergistic cancer starving-like/gas therapy. Angew Chem Int Ed, 2017, 56: 1229–1233CrossRefGoogle Scholar
  19. 19.
    Zhang Y, Yang Y, Jiang S, et al. Degradable silver-based nano-platform for synergistic cancer starving-like/metal ion therapy. Mater Horiz, 2019, 6: 169–175CrossRefGoogle Scholar
  20. 20.
    Zhang L, Wan SS, Li CX, et al. An adenosine triphosphate-responsive autocatalytic fenton nanoparticle for tumor ablation with self-supplied H2O2 and acceleration of Fe(III)/Fe(II) conversion. Nano Lett, 2018, 18: 7609–7618CrossRefGoogle Scholar
  21. 21.
    Yang Y, Lu Y, Abbaraju PL, et al. Stepwise degradable nanocarriers enabled cascade delivery for synergistic cancer therapy. Adv Funct Mater, 2018, 28: 1800706CrossRefGoogle Scholar
  22. 22.
    Li J, Li Y, Wang Y, et al. Polymer prodrug-based nanoreactors activated by tumor acidity for orchestrated oxidation/chemotherapy. Nano Lett, 2017, 17: 6983–6990CrossRefGoogle Scholar
  23. 23.
    Yu Z, Zhou P, Pan W, et al. A biomimetic nanoreactor for synergistic chemiexcited photodynamic therapy and starvation therapy against tumor metastasis. Nat Commun, 2018, 9: 5044CrossRefGoogle Scholar
  24. 24.
    Chang K, Liu Z, Fang X, et al. Enhanced phototherapy by nano-particle-enzyme via generation and photolysis of hydrogen peroxide. Nano Lett, 2017, 17: 4323–4329CrossRefGoogle Scholar
  25. 25.
    Li SY, Cheng H, Xie BR, et al. Cancer cell membrane camouflaged cascade bioreactor for cancer targeted starvation and photo-dynamic therapy. ACS Nano, 2017, 11: 7006–7018CrossRefGoogle Scholar
  26. 26.
    Lü B, Chen Y, Li P, et al. Stable radical anions generated from a porous perylenediimide metal-organic framework for boosting near-infrared photothermal conversion. Nat Commun, 2019, 10: 767CrossRefGoogle Scholar
  27. 27.
    Ma Y, Bao J, Zhang Y, et al. Mammalian near-infrared image vision through injectable and self-powered retinal nanoantennae. Cell, 2019, 177: 243–255.e15CrossRefGoogle Scholar
  28. 28.
    Zhang Z, Jayakumar MKG, Zheng X, et al. Upconversion superballs for programmable photoactivation of therapeutics. Nat Commun, 2019, 10: 4586CrossRefGoogle Scholar
  29. 29.
    All AH, Zeng X, Teh DBL, et al. Expanding the toolbox of up-conversion nanoparticles for in vivo optogenetics and neuromodulation. Adv Mater, 2019, 31: 1803474CrossRefGoogle Scholar
  30. 30.
    Dong S, Xu J, Jia T, et al. Upconversion-mediated ZnFe2O4 nanoplatform for NIR-enhanced chemodynamic and photodynamic therapy. Chem Sci, 2019, 10: 4259–4271CrossRefGoogle Scholar
  31. 31.
    Zhong Y, Ma Z, Wang F, et al. In vivo molecular imaging for immunotherapy using ultra-bright near-infrared-IIb rare-earth nanoparticles. Nat Biotechnol, 2019, 37: 1322–1331CrossRefGoogle Scholar
  32. 32.
    Zhang M, Zheng W, Liu Y, et al. A new class ofblue-LED-excitable NIR-II luminescent nanoprobes based on lanthanide-doped CaS nanoparticles. Angew Chem Int Ed, 2019, 58: 9556–9560CrossRefGoogle Scholar
  33. 33.
    Gao Y, Li R, Zheng W, et al. Broadband NIR photostimulated luminescence nanoprobes based on CaS:Eu2+, Sm3+ nanocrystals. Chem Sci, 2019, 10: 5452–5460CrossRefGoogle Scholar
  34. 34.
    Lucky SS, Muhammad Idris N, Li Z, et al. Titania coated upconversion nanoparticles for near-infrared light triggered photo-dynamic therapy. ACS Nano, 2015, 9: 191–205CrossRefGoogle Scholar
  35. 35.
    Gu Y, Guo Z, Yuan W, et al. High-sensitivity imaging of time-domain near-infrared light transducer. Nat Photonics, 2019, 13: 525–531CrossRefGoogle Scholar
  36. 36.
    Qian HS, Guo HC, Ho PCL, et al. Mesoporous-silica-coated up-conversion fluorescent nanoparticles for photodynamic therapy. Small, 2009, 5: 2285–2290CrossRefGoogle Scholar
  37. 37.
    Liang T, Li Z, Wang P, et al. Breaking through the signal-to-background limit of upconversion nanoprobes using a target-modulated sensitizing switch. J Am Chem Soc, 2018, 140: 14696–14703CrossRefGoogle Scholar
  38. 38.
    Li X, Sun L, Yang X, et al. Enhancing the colorimetric detection of H2O2 and ascorbic acid on polypyrrole coated fluconazole-functionalized POMOFs. Analyst, 2019, 144: 3347–3356CrossRefGoogle Scholar
  39. 39.
    Li M, Long S, Kang Y, et al. De novo design of phototheranostic sensitizers based on structure-inherent targeting for enhanced cancer ablation. J Am Chem Soc, 2018, 140: 15820–15826CrossRefGoogle Scholar
  40. 40.
    Zhao W, Hu J, Gao W. Glucose oxidase-polymer nanogels for synergistic cancer-starving and oxidation therapy. ACS Appl Mater Interfaces, 2017, 9: 23528–23535CrossRefGoogle Scholar

Copyright information

© Science China Press and Springer-Verlag GmbH Germany, part of Springer Nature 2020

Authors and Affiliations

  • Leli Zeng (曾乐立)
    • 1
    • 2
  • Kai Huang (黄凯)
    • 1
  • Yilin Wan (万艺林)
    • 1
  • Jing Zhang (张景)
    • 1
  • Xikuang Yao (姚锡矿)
    • 1
  • Chao Jiang (蒋超)
    • 1
  • Jing Lin (林静)
    • 1
  • Peng Huang (黄鹏)
    • 1
    Email author
  1. 1.Marshall Laboratory of Biomedical EngineeringInternational Cancer Center, Laboratory of Evolutionary Theranostics (LET), School of Biomedical Engineering, Shenzhen University Health Science CenterShenzhenChina
  2. 2.Research Centre, The Seventh Affiliated HospitalSun Yat-sen UniversityShenzhenChina

Personalised recommendations